Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atropine for Children and Adolescent Myopia Progression Study (ACAMP)

NCT03949101 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.

NCT NCT03949101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03949101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atropine for Children and Adolescent Myopia Progression Study (ACAMP)
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Phase 4
Overall status
Unknown status
Start date
May 8, 2019
Completion date
September 1, 2021
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia